Nuvalent Inc (NUVL) USD0.0001 A
Sell:$37.26Buy:$108.55
$2.52
(2.63%)
NASDAQ:
0.22%
0.22%Market closed |
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$37.26
Buy:$108.55
Change:$2.52
(2.63%)
$2.52
(2.63%)Market closed |
Prices delayed by at least 15 minutes
Sell:$37.26
Buy:$108.55
Change:$2.52
(2.63%)
$2.52
(2.63%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 30 October 2025 | Deborah Ann (Deb) MillerChief Legal/Compliance Officer | Sell Option/Award related | 700 | $96.65 | $67,655.00 | 70,186 |
| 30 October 2025 | Deborah Ann (Deb) MillerChief Legal/Compliance Officer | Sell Option/Award related | 1,273 | $97.98 | $124,728.54 | 68,913 |
| 30 October 2025 | Deborah Ann (Deb) MillerChief Legal/Compliance Officer | Sell Option/Award related | 500 | $99.66 | $49,830.00 | 68,413 |
| 30 October 2025 | Deborah Ann (Deb) MillerChief Legal/Compliance Officer | Sell Option/Award related | 600 | $100.96 | $60,576.00 | 67,813 |
| 30 October 2025 | Deborah Ann (Deb) MillerChief Legal/Compliance Officer | Sell Option/Award related | 2,121 | $102.00 | $216,342.00 | 65,692 |
| 30 October 2025 | Deborah Ann (Deb) MillerChief Legal/Compliance Officer | Sell Option/Award related | 3,733 | $102.88 | $384,051.04 | 61,959 |
| 30 October 2025 | Deborah Ann (Deb) MillerChief Legal/Compliance Officer | Sell Option/Award related | 3,491 | $103.90 | $362,714.90 | 58,468 |
| 30 October 2025 | Darlene NociChief Level Officer | Sell Option/Award related | 57 | $98.91 | $5,637.87 | 51,977 |
| 30 October 2025 | Darlene NociChief Level Officer | Sell Option/Award related | 350 | $100.69 | $35,241.50 | 51,627 |
| 30 October 2025 | Darlene NociChief Level Officer | Sell Option/Award related | 1,170 | $102.07 | $119,421.90 | 50,457 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 11 December 2024 | BAIN CAPITAL LIFE SCIENCES INVESTORS LLCHedge Fund | Sell Regular sell transaction (market) | 1,250,000 | $88.00 | $110,000,000.00 | 1,447,267 |
| 28 October 2025 | Matthew D. (Matt) ShairOther Level A | Sell Regular sell transaction (market) | 32,455 | $100.27 | $3,254,262.85 | 1,383,044 |
| 18 February 2025 | James Richard PorterPresident/CEO | Sell Option/Award related | 26,200 | $78.44 | $2,055,128.00 | 249,862 |
| 30 September 2025 | Alexandra (Alex) BalcomCFO | Sell Option/Award related | 20,000 | $85.06 | $1,701,200.00 | 61,734 |
| 15 July 2025 | James Richard PorterPresident/CEO | Sell Option/Award related | 19,997 | $82.31 | $1,645,953.07 | 250,662 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.